Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) FCF Margin (2020 - 2025)

Treace Medical Concepts' FCF Margin history spans 6 years, with the latest figure at 16.67% for Q4 2025.

  • For Q4 2025, FCF Margin fell 608.0% year-over-year to 16.67%; the TTM value through Dec 2025 reached 13.86%, up 943.0%, while the annual FY2025 figure was 13.86%, 943.0% up from the prior year.
  • FCF Margin reached 16.67% in Q4 2025 per TMCI's latest filing, up from 23.7% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 1.25% in Q1 2025 to a low of 52.48% in Q2 2022.
  • Average FCF Margin over 5 years is 24.45%, with a median of 22.76% recorded in 2024.
  • Peak YoY movement for FCF Margin: plummeted -3095bps in 2022, then surged 2306bps in 2025.
  • A 5-year view of FCF Margin shows it stood at 14.03% in 2021, then decreased by -10bps to 15.45% in 2022, then skyrocketed by 82bps to 2.76% in 2023, then tumbled by -284bps to 10.6% in 2024, then crashed by -57bps to 16.67% in 2025.
  • Per Business Quant, the three most recent readings for TMCI's FCF Margin are 16.67% (Q4 2025), 23.7% (Q3 2025), and 16.5% (Q2 2025).